Androgeos spol. s r.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials
• Prostate cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Ferring Pharmaceuticals2 trials
• Astellas Pharma Global Development, Inc.1 trial

Running trials

• Recruiting

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· Phase 3· Ferring Pharmaceuticals· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· Phase 3· Ferring Pharmaceuticals· Source

• Active, not recruiting

  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

  NCT02960022· Phase 2· Astellas Pharma Global Development, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting